Experienced life science profile and largest investor joins the Brain+ team as Strategic Partnerships Advisor to accelerate pharma partner deals
Copenhagen, Denmark, October 10, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)
· John Haurum, a well-known profile in the European life science community, and the largest shareholder in Brain+, joins the Brain+ team to help develop and close new strategic pharma partnerships
· John holds 4.2 million Brain+ shares, corresponding to a 9.4% ownership, and recently announced commitment to exercise all his 2.9 million TO 2 warrants
· Brain+ is in dialogue with major Alzheimer’s pharma players and has entered a phase, where additional expertise in deal making and partnering is